Letter 2: Prevention of perioperative thromboembolism in patients with atrial fibrillation (Br J Surg 2007; 94: 1351-1355).
Potter
J
J
D000925:Anticoagulants / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000150:complications*; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D007431:Intraoperative Complications / Q000517:prevention & control*; D017762:Nadroparin / Q000627:therapeutic use; D012307:Risk Factors; D013923:Thromboembolism / Q000517:prevention & control*; D014812:Vitamin K / Q000037:antagonists & inhibitors*
D000925:Anticoagulants; D017762:Nadroparin; D014812:Vitamin K; D006493:Heparin